Astaxanthin improves fatty acid dysregulation in diabetes by controlling the AMPK-SIRT1 pathway

Due to the rising prevalence of metabolic disorders, including type 2 diabetes (T2DM), new prevention and treatment strategies are needed. The aim was to examine the effect of astaxanthin (AST) on the major regulatory metabolism pathway SIRT-MAPK and fatty acid (FA) profile of plasma in patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Taghiyar, Sana, Pourrajab, Fatemeh, Aarabi, Mohammad Hosein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Leibniz Research Centre for Working Environment and Human Factors 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391612/
https://www.ncbi.nlm.nih.gov/pubmed/37534224
http://dx.doi.org/10.17179/excli2023-6132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391612/
https://www.ncbi.nlm.nih.gov/pubmed/37534224
http://dx.doi.org/10.17179/excli2023-6132

Ejemplares similares